Laboratory monitoring should continue for several weeks after discontinuation, particularly hemoglobin A1c and weight measurements, to assess metabolic trajectory and guide subsequent management
The following sections apply this perspective to specific physiological domains, beginning with metabolic and energy-balance peptides beyond the incretin family
Semaglutide (Wegovy) and tirzepatide (Zepbound) have demonstrated significant average weight loss14.9% and 20.9% of body weight at approximately one year, respectively
If tirzepatide has been frozen, it should be discarded
Possible Side Effects That May Matter More on Blood Thinners While the standard GLP-1 side effects are well-documented, a few specific symptoms merit extra attention if you are currently taking an anticoagulant or antiplatelet medication: When Should Someone Talk to a Healthcare Provider
Im really excited about our paper and I think we hopefully contributed an important piece to the literature there, but theres still so much that I think we havent really explored in the necessary detail yet